Login to Your Account



NicOx Raising €130M; Receives €5M For Antihypertensive Drug

By James Etheridge


Wednesday, January 24, 2007

PARIS - NicOx SA is seeking to raise about €130 million (US$168.4 million) in a capital increase which involves the offer of new ordinary shares with existing shareholders having preferential subscription rights. The subscription price will be announced Jan. 29. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription